The Medical Unit of ZAHORANSKY AG will once again be represented at this year's MedtecLIVE in Stuttgart (June 18-20 2024) at the joint stand of the VDMA Medical Technology Working Group, where it will present its extensive solution expertise in the field of mold making and injection molding-related automation. ZAHORANSKY is clearly focusing on the topic of “plastic instead of glass”. After all, manufacturing pharmaceutical primary packaging from COC/COP-based materials offers significant advantages when it comes to filling and storing sensitive pharmaceuticals. The production of plastic-based containers is much more reliable than the production of glass containers. This is particularly the case with staked needle pre-filled syringes (staked needle PFS), as the needle can be positioned more flexibly before overmolding and is not melted or glued in. In addition, there is a reduced risk of breakage, which requires less care during handling, transportation and storage. Finally, the durability of highly sensitive medicines is significantly extended thanks to the advantageous barrier properties of plastic-based containers.
 |
Depending on the product and customer requirements, ZAHORANSKY systems can also be equipped with any number of camera and other inspection systems for quality assurance, such as 100% inspection via an integrated X-ray system. With pioneering state-of-the-art technologies and highly developed injection molding and automation solutions, ZAHORANSKY thus covers the entire manufacturing cycle for pharmaceutical primary packaging, consumables for laboratory analysis and in-vitro diagnostics as well as drug delivery systems. “MedtecLIVE is the ideal platform for us to present our high-performance solution portfolio for the requirements of the pharmaceutical industry and its CMOs and CDMOs from a single source,” says Marc Schmidt, Account Development Manager at ZAHORANSKY.
In the field of medical technology, ZAHORANSKY offers comprehensive solutions to produce complex plastic, hybrid and glass replacement products. The company also has extensive expertise and experience with injection molds - including upstream and downstream automation and quality control as well as the integration of injection molding machines and system components.
This offers manufacturers of pharmaceutical primary packaging various advantages in terms of risk minimization and time savings, such as fewer interfaces, less engineering effort, reduced complexity, detailed simulations using so-called digital twins and intuitive cross-system human-machine communication. All of this ensures the greatest possible implementation and process reliability, a predictable time-to-market, optimized overall system effectiveness, reduced unit costs and finally, efficient use of personnel and resources. “We have been thinking, developing and implementing mold making and automation under one roof for over 15 years. In doing so, we build on our extensive and long-standing expertise in industrial plastics production, particularly in the areas of oral hygiene and brush production,” explains Marc Schmidt.
